ArticleJournal of enzyme inhibition and medicinal chemistry2023

Flavone-based dual PARP-Tubulin inhibitor manifesting efficacy against endometrial cancer.

Sachin Sharma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.